TET3 and acute myeloid leukemia: Both univariate and multivariate analysis showed that TET3 expression may act as an independent prognostic factor for OS and DFS in total AML (Table 1, P=0.011 and 0.026, respectively) and non-M3 AML (Table 2, P=0.038 and 0.026, respectively).